Highlights and Quick Summary
- Free Cash Flow Growth for the quarter ending September 30, 2022 was -23.74% (a -98.32% decrease compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Growth increased by 43.44%
- Annual Free Cash Flow Growth for 2021 was -30.7% (a 1674.57% increase from previous year)
- Annual Free Cash Flow Growth for 2020 was -1.73% (a -94.4% decrease from previous year)
- Annual Free Cash Flow Growth for 2019 was -30.92% (a -265.88% decrease from previous year)
- Twelve month Free Cash Flow Growth ending September 30, 2022 was -52.85% (a -21.23% decrease compared to previous quarter)
- Twelve month trailing Free Cash Flow Growth increased by 72.15% year-over-year
Trailing Free Cash Flow Growth for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -52.85% | -67.09% | -4.58% | -30.7% |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Growth of Biodesix, Inc.
Most recent Free Cash Flow Growthof BDSX including historical data for past 10 years.Interactive Chart of Free Cash Flow Growth of Biodesix, Inc.
Biodesix, Inc. Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -23.74% | -1411.19% | -11.32% | – |
| 2021 | -16.55% | -73.65% | 116.57% | -153.09% | -30.7% |
| 2020 | – | -49.26% | 70.07% | 41.76% | -1.73% |
| 2019 | – | – | – | -625.6% | -30.92% |
| 2018 | – | – | – | – | 18.64% |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research